Unlocking Cures for Pediatric Cancer With Artificial Intelligence
1. Purpose
Executive Order 14355 aims to harness artificial intelligence to drive innovation in the prevention and treatment of childhood diseases, with a strong emphasis on addressing pediatric cancer.
2. Key Actions And Directives
- Develop AI-Driven Solutions: Enhance the Childhood Cancer Data Initiative (CCDI) through AI to improve diagnostics, optimize treatments, and advance pediatric cancer research.
- Increase Federal Investment: Commit $50 million annually for a decade to support research and development in childhood cancer.
- Engage Make America Healthy Again (MAHA) Commission: Coordinate with the MAHA Commission to create innovative AI applications for diagnosing and treating pediatric cancer.
3. Important Points
- Rising Pediatric Cancer Rates: Pediatric cancer is the leading cause of disease-related deaths among children ages 1-19 in the U.S., with incidence rates increasing by over 40% since 1975.
- CCDI's Role in Research: The Childhood Cancer Data Initiative (CCDI) represents a significant federal investment aimed at catalyzing advancements in understanding and treating pediatric cancer.
- Patient Data Interoperability: The order underscores the need for patient data interoperability in AI applications, prioritizing patient and parental control over health information.
- Executive Authority Maintenance: The order clarifies that it honors the existing legal authorities of executive branches and agencies, ensuring continuity of operations and mandates.
- Publication Costs Covered: The Department of Health and Human Services will bear all costs related to the publication of this executive order.
Disclaimer: ExecBrief's are AI generated, Please verify with the original source to confirm
Click here to provide feedback to help us improve your experience!
Comments